See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.
Pharmacology Core
eagle-i ID
http://tsu.eagle-i.net/i/0000014e-2109-b5e8-2350-d5a280000000
Resource Type
Properties
-
-
Resource Description
-
There is an increasing need for a more efficient health care system including novel drugs that help to relieve the health disparity in minority and urban communities. The Pharmacology Core helps TSU achieve its goal of improving biomedical research on minority health. In conjunction with the other RCMI research cores and laboratories, lead compounds can be screened and analyzed at the Pharmacology Core facility, and will be optimized and further developed to obtain preclinical efficacy, toxicity and pharmacokinetic information, and eventually translated to Phase 0-I clinical trials. The following resources are available in the Pharmacology Core facility: drug preformulation and formulation on promising compounds; novel nanotechnology-based drug formulation, characterization and delivery techniques for in vitro and in vivo studies; nanoparticle imaging and analysis instruments, and methods for molecule and particle characterization; mass spectrometry instruments and capability of qualitative and quantitative measurement of small molecules; and small animal facility for preclinical and clinical pharmacokinetics and pharmacodynamics studies.
-
-
Additional Name
-
Texas Southern University
-
-
Contact
-
Huan Xie
-
-
PI
-
Oyekan, Adebayo, D.V.M, Ph.D., F.A.H.A.
-
-
Performs Technique
-
Instrumentation technical support
-
-
Director
-
Huan Xie
-
-
PI (co-Investigator)
-
Liang, Dong, Ph.D.